VOLPI, Nicola
 Distribuzione geografica
Continente #
NA - Nord America 37.975
AS - Asia 20.089
EU - Europa 19.791
SA - Sud America 2.599
AF - Africa 434
OC - Oceania 100
Continente sconosciuto - Info sul continente non disponibili 35
Totale 81.023
Nazione #
US - Stati Uniti d'America 37.391
SG - Singapore 6.424
GB - Regno Unito 6.222
CN - Cina 5.486
IT - Italia 3.497
SE - Svezia 3.375
HK - Hong Kong 2.373
BR - Brasile 1.939
VN - Vietnam 1.857
DE - Germania 1.309
FI - Finlandia 1.096
UA - Ucraina 1.013
TR - Turchia 888
FR - Francia 870
KR - Corea 864
RU - Federazione Russa 684
IN - India 440
BG - Bulgaria 403
ID - Indonesia 273
CA - Canada 260
AR - Argentina 219
JP - Giappone 217
NL - Olanda 217
MX - Messico 216
BD - Bangladesh 194
PL - Polonia 161
ES - Italia 149
IQ - Iraq 137
PK - Pakistan 125
ZA - Sudafrica 109
IE - Irlanda 104
CH - Svizzera 103
CL - Cile 91
AE - Emirati Arabi Uniti 90
CO - Colombia 83
TH - Thailandia 80
AU - Australia 79
MY - Malesia 77
EC - Ecuador 72
IR - Iran 68
VE - Venezuela 67
BE - Belgio 64
MA - Marocco 61
PE - Perù 59
LT - Lituania 57
AT - Austria 55
EG - Egitto 55
GR - Grecia 54
UZ - Uzbekistan 54
PH - Filippine 52
SA - Arabia Saudita 49
DZ - Algeria 47
TN - Tunisia 47
RO - Romania 46
CZ - Repubblica Ceca 42
TW - Taiwan 40
KE - Kenya 37
PT - Portogallo 37
RS - Serbia 37
IL - Israele 36
SK - Slovacchia (Repubblica Slovacca) 36
NP - Nepal 35
JO - Giordania 34
DK - Danimarca 32
EU - Europa 25
PY - Paraguay 25
KZ - Kazakistan 23
QA - Qatar 23
BO - Bolivia 22
AZ - Azerbaigian 21
HU - Ungheria 21
CR - Costa Rica 20
NZ - Nuova Zelanda 20
UY - Uruguay 20
LB - Libano 17
AL - Albania 15
BH - Bahrain 15
HR - Croazia 15
NG - Nigeria 15
SI - Slovenia 15
JM - Giamaica 14
NO - Norvegia 14
OM - Oman 14
BY - Bielorussia 13
DO - Repubblica Dominicana 12
ET - Etiopia 12
PR - Porto Rico 12
HN - Honduras 11
SY - Repubblica araba siriana 11
MD - Moldavia 10
PS - Palestinian Territory 10
GE - Georgia 9
KG - Kirghizistan 9
TT - Trinidad e Tobago 9
AM - Armenia 8
AO - Angola 8
PA - Panama 8
CI - Costa d'Avorio 7
KW - Kuwait 7
MK - Macedonia 7
Totale 80.905
Città #
Singapore 4.463
Southend 4.419
Santa Clara 3.499
Ashburn 3.441
Fairfield 3.403
Woodbridge 2.606
Hong Kong 2.315
Chandler 2.100
Houston 2.072
Jacksonville 2.004
Hefei 1.884
Stockholm 1.809
Dearborn 1.557
Seattle 1.221
Wilmington 1.221
Ann Arbor 1.185
Beijing 1.153
Cambridge 1.102
San Jose 1.005
London 958
Nyköping 950
Helsinki 720
Seoul 649
The Dalles 581
Ho Chi Minh City 574
Council Bluffs 541
Los Angeles 536
Hanoi 470
Modena 447
New York 435
Princeton 414
Chicago 391
Sofia 380
Izmir 370
Eugene 356
Milan 351
San Diego 338
Lauterbourg 308
Buffalo 293
Redwood City 220
Moscow 215
Jakarta 169
Shanghai 160
Rome 159
Salt Lake City 152
São Paulo 148
Columbus 142
Tokyo 131
Des Moines 127
Dallas 123
Orem 108
Frankfurt am Main 99
Falkenstein 94
Munich 92
Bologna 89
Dublin 85
Amsterdam 84
Falls Church 84
Naples 84
Haiphong 81
Dong Ket 80
Toronto 78
Da Nang 76
Mexico City 76
Tampa 74
Guangzhou 66
Paris 66
Rio de Janeiro 66
Chennai 65
Istanbul 65
Kent 63
Elk Grove Village 62
Brooklyn 61
Norwalk 60
Atlanta 59
Boardman 58
Warsaw 56
Lesquin 55
Nanjing 55
Turku 54
Belo Horizonte 53
Baghdad 51
San Francisco 51
Phoenix 50
Brussels 49
Madrid 49
Bangkok 48
Florence 48
Miano 47
Kunming 45
Nuremberg 44
Sterling 44
Jinan 43
Tashkent 43
Buenos Aires 41
Johannesburg 41
Leipzig 41
Manchester 41
New Delhi 41
Redondo Beach 41
Totale 57.373
Nome #
Adenylate pool and energy charge in human lymphocytes and granulocytes irradiated at 632 nm (HeNe Laser) 1.956
BIOCHIMICA STRUTTURALE, FUNZIONALE E METABOLICA 1.222
ACTIVITY STUDIES OF CHARACTERIZED, STANDARDIZED AND HIGHLY PURIFIED PROPOLIS EXTRACT 696
Recent advances in analytical approaches for the standardization and quality of polyphenols of propolis 618
Two analytical approaches to the evaluation of chondroitin sulfate in european food supplements. 581
A 96-well assay for uronic acid carbazole reaction 539
Chemical Composition and Antioxidant Activity of Propolis Prepared in Different Forms and in Different Solvents Useful for Finished Products 501
MOLECULAR COMPOSITION OF ACTIVE CHIOS MASTIC GUM COMPOUNDS, TERPENES, FOR USE IN COSMETIC, NUTRACEUTICAL, MEDICAL DEVICES AND PHARMACEUTICAL APPLICATIONS. 480
Shockwave lithotripsy and the protective role of inosine: Early and late evaluation in an experimental model 420
Differences among Three Branded Formulations of Hyaluronic Acid: Data from Environmental Scanning Electron Microscope Profile, Rheology Behavior and Biological Activity 402
ZFP36 stabilizes RIP1 via degradation of XIAP and cIAP2 thereby promoting ripoptosome assembly 402
Structural characterization of the skin glycosaminoglycans in patients with pseudoxanthoma elasticum 369
Determination of molecular mass values of chondroitin sulfates by fluorophore-assisted carbohydrate electrophoresis (FACE) 354
Capillary blotting of glycosaminoglycans on nitrocellulose membranes after agarose-gel electrophoresis separation 353
Beta-amyloid fibrillation and/or hyperhomocysteinemia modify striatal patterns of hyaluronic acid and dermatan sulfate: possible role in the pathogenesis of Alzheimer's disease. 351
Chondroitin Sulfate and Glucosamine as Disease Modifying Anti- Osteoarthritis Dru gs (DMOADs). 346
Purification and structural elucidation of chondroitin sulfate/dermatan sulfate from Atlantic bluefin tuna (Thunnus thynnus) skins and their anticoagulant and ACE inhibitory activities 342
Chondroitin sulfate/dermatan sulfate from corb (Sciaena umbra) skin: Purification, structural analysis and anticoagulant effect 341
12 year follow up of enzyme-replacement therapy in two siblings with attenuated mucopolysaccharidosis I: the important role of early treatment. 341
Plasmatic and urinary glycosaminoglycans characterization in mucopolysaccharidosis II Patient treated with enzyme-replacement therapy with Idursulfase 338
Chondroitin sulfate. Structure, role and pharmacological activity. Nicola Volpi (Editor) 337
Analytical aspects of pharmaceutical grade chondroitin sulfates 334
Comparison of CPC and CETAB extractive procedures for quantification and characterization of human urinary glycosaminoglycans 333
Analytical Methods for Assessing Chondroitin Sulfate in Human Plasma. 329
activity of chondroitin ABC lyase on dermatan sulfate partially degraded by cupric-ion-mediated free-radical treatment 325
Mental retardation in mucopolysaccharidoses correlates with high molecular weight urinary heparan sulphate derived glucosamine. 324
Anomalous structure of urinary glycosaminoglycans in patients with pseudoxanthoma elasticum 323
Analysis of flavonoids from propolis by on-line HPLC-electrospray mass spectrometry 323
Isolation, Purification and Structural Characterestics of Chondroitin Sulfate from Smooth hound Cartilage: In vitro Anticoagulant and Antiproliferative Properties 319
Capillary electrophoresis separation of human milk neutral and acidic oligosaccharides derivatized with 2-aminoacridone. 316
Electrophoretic approaches to the analysis of complex polysaccharides 313
Separation of flavonoids and phenolic acids from propolis by capillary zone electrophoresis 311
Purification and characterization of heparin from the Italian clam Callista chione 309
Comparative analysis of fatty acid profile in three eutardigrade species 309
Biological effects and potential mechanisms of action of Pistacia lentiscus Chios mastic extract in Caco-2 cell model 308
Adsorption of glycosaminoglycans onto coral - a new possible implant biomaterials for regeneration therapy 306
Agarose-gel electrophoresis for the diagnosis of mucopolysaccharidoses 306
Therapeutic applications of glycosaminoglycans 306
Glycosaminoglycan Blotting and Detection After Electrophoresis Separation 303
Le arilsolfatasi come glicoconiugati: aspetti biochimico - comparati della loro regolazione 302
Agarose-gel electrophoresis for the quality assurance and purity of heparin formulations 301
Chondroitin sulfate in normal human plasma is modified depending on the age. Its evaluation in patients with pseudoxanthoma elasticum 300
Analysis of glycosaminoglycan-derived, pre-column 2-aminoacridone-labeled disaccharides using liquid chromatography-fluorescence and -mass spectrometric detection. 298
Purification, Structural Characterization and Antiproliferative Properties of Chondroitin Sulfate/Dermatan Sulfate from Tunisian Fish Skins 296
effects of glycosaminoglycans on u-937 leukemia-cell proliferation and differentiation - structure-function relationship 295
Oral bioavailability of chondroitin sulfate (Condrosulf (R)) and its constituents in healthy male volunteers 294
Composition and structure elucidation of human milk glycosaminoglycans 294
Separation of keratan-sulfate-derived disaccharides by high-performance liquid chromatography and postcolumn derivatization with 2-cyanoacetamide and fluorimetric detection 293
Shift of optimal pH in arylsulphatase from Mollusca depending on temperature 292
Atheroprotective remodelling of vascular dermatan sulphate proteoglycans in response to hypercholesterolaemia in a rat model 292
Recent advances on separation and characterization of human milk oligosaccharides. 292
Purification, compositional analysis, and anticoagulant capacity of chondroitin sulfate/dermatan sulfate from bone of corb (Sciaena umbra). 291
Glycosaminoglycan content in term and preterm milk during the first month of lactation 289
The protein profile of fibroblasts: the role of proteomics. 289
Purification and characterization of hyaluronic acid from the mollusc bivalve Mytilus galloprovincialis 283
High-performance capillary electrophoresis separation of hyaluronan oligosaccharides produced by Streptomyces hyalurolyticus hyaluronate lyase 283
Capillary electrophoresis of bacterial (lipo)polysaccharides 282
Composition of urinary glycosaminoglycans in a patient with pseudoxanthoma elasticum and familial Mediterranean fever 281
Glycosaminoglycan composition of the large freshwater mollusc bivalve Anodonta anodonta 280
Multi dynamic extraction: An innovative method to obtain a standardized chemically and biologically reproducible polyphenol extract from poplar-type propolis to be used for its anti-infective properties 280
Isolation and structural characterization of chondroitin sulfate from bony fishes 279
Fine characterization of mitral valve glycosaminoglycans and their modification with degenerative disease. 278
Characterization of Oversulfated Chondroitin Sulfate Rich in 4,6-O-disulfated Disaccharides in Breast Cyst Fluids Collected from Human Breast Gross Cysts. 278
Determination of urinary hexosamines for diagnosis of bladder pain syndrome 277
Effect of 6 years of enzyme replacement therapy on plasma and urine glycosaminoglycans in attenuated MPS I patients 277
1H and 13C Characterization of Chondroitin Sulphate from Porcine Trachea and Shark Cartilage 277
Capillary electrophoresis of complex natural polysaccharides 275
Activity of chondroitin ABC lyase and hyaluronidase on free-radical degraded chondroitin sulfate 275
Simultaneous detection of submicrogram quantities of hyaluronic acid and dermatan sulfate on agarose-gel by sequential staining with toluidine blue and Stains-All 274
Electrophoresis for the analysis of heparin purity and quality. 273
Human Milk Glycosaminoglycans Inhibit in vitro the Adhesion of Escherichia coli and Salmonella fyris to Human Intestinal Cells 272
Metabolic fate of milk glycosaminoglycans in breastfed and formula fed newborns. 269
Improvement in the high-performance liquid chromatography malondialdehyde level determination in normal human plasma 267
Selective treatment to reduce contamination of propolis by polycyclic aromatic hydrocarbons (PAHs) still preserving its active polyphenol component and antioxidant activity 267
Safety assessment of non-animal chondroitin sulfate sodium: Subchronic study in rats, genotoxicity tests and human bioavailability. 267
Mass spectrometry characterization of Escherichia coli K4 oligosaccharides from 2-mers to more than 20-mers 266
Fine structural characterization of chondroitin sulfate in urine of bladder pain syndrome subjects 265
EFFECTS OF LOW-POWER 632 NM RADIATION (HENE LASER) ON A HUMAN CELL-LINE - INFLUENCE ON ADENYLNUCLEOTIDES AND CYTOSKELETAL STRUCTURES 263
1H and 13C Characterization of Chondroitin Sulphate from Beef Trachea 263
Recent advances in capillary electrophoresis separation of monosaccharides, oligosaccharides and polysaccharides 263
Anomalous structure of urinary glycosaminoglycans in patients with pseudoxanthoma elasticum 262
Characterization of a low-sulfated chondroitin sulfate isolated from the hemolymph of the freshwater snail Planorbarius corneus 261
effect of low-frequency electromagnetic pulsed-field stimulation on yeast fermentation in presence of dicarboxylic and tricarboxylic acids 260
Direct and specific recognition of glycosaminoglycans by antibodies after their separation by agarose gel electrophoresis and blotting on cetylpyridinium chloride-treated nitrocellulose membranes 260
Quantitative and Qualitative Evaluation of ChondroitinSulfate in Dietary Supplements 256
Mild mental retardation and low levels of urinary heparan sulfate in a patient with the attenuated phenotype of Mucopolysaccharidosis type IIIA. 256
Capillary electrophoresis of Biomolecules. Methods and Protocols. 255
Isolation and characterization of a heparin with high anticoagulant activity from the clam Tapes phylippinarum: evidence for the presence of a high content of antithrombin III binding site 254
IMPLICANCIA DE LAS CADENAS DE GLICOSAMINOGLICANOS DE LA MATRIZ EXTRACELULAR EN LA “ATERO-RESISTENCIA” VASCULAR. 254
Plasmatic kinetics of dermatan sulfate during enzyme replacement therapy with iduronate-2-sulfatase in a mucopolysaccharidosis II Patient 253
Influence of charge density, sulfate group position and molecular mass on adsorption of chondroitin sulfate onto coral 252
Anti-zika virus and anti-usutu virus activity of human milk and its components 252
Analysis of normal levels of free glycosaminoglycans in urine and plasma in adults 252
Glycosaminoglycan levels and structure in a mucopolysaccharidosis IIIA mice and the effect of a highly secreted sulfamidase engineered to cross the blood-brain barrier 251
Composition and structure of glycosaminoglycans in DBS from 2-3-day-old newborns for the diagnosis of mucopolysaccharidosis 251
Approccio globale alle mucopolisaccaridosi: applicazione di metodi altamente specifici per la diagnosi neonatale: risultati preliminari su campione di urina 250
Human milk glycosaminoglycans: the state of the art and future perspectives 249
Novel reverse-phase ion pair-high performance liquid chromatography separation of heparin, heparan sulfate and Low molecular weight-heparins disaccharides and oligosaccharides. 248
Plasmatic and urinary glycosaminoglycan profile in a patient affected by multiple sulfatase deficiency 248
Quantitative capillary electrophoresis determination of oversulfated chondroitin sulfate as a contaminant in heparin preparations 247
Totale 33.589
Categoria #
all - tutte 286.463
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 286.463


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021811 0 0 0 0 0 0 0 0 0 0 434 377
2021/20225.728 214 844 516 425 158 312 312 251 718 462 801 715
2022/20236.174 692 581 425 543 684 905 183 688 819 74 285 295
2023/20244.542 227 281 197 571 1.042 351 394 584 128 134 213 420
2024/202513.778 518 194 225 969 2.501 1.889 773 1.092 1.542 898 1.500 1.677
2025/202624.383 1.406 968 2.446 2.445 3.430 2.160 3.074 1.515 4.153 2.267 519 0
Totale 81.454